OMEGA-3-FATTY ACIDS IN CHILDREN WITH SICKLE CELL DISEASE
ConditionSickle Cell Disease (SCD)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age5-18
SponsorUniversity of Alabama at Birmingham
About this trial
The purpose of this feasibility study is to investigate the role of a dietary supplement in modulating the gut microbiota and improving pain outcomes in children with sickle cell disease (SCD).
Eligibility criteria
Qualifiers
None
Disqualifiers
current use of antibiotics except prophylactic penicillin
current use of pre-or probiotic supplements
current use of PPI therapy
pregnant or lactating females
Trial design
Treatments tested in this trial
- Flaxseed
Treatment groups
20 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov